We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 71

European Commission publishes report on external reference pricing for medicinal products

  • Hogan Lovells
  • -
  • European Union
  • -
  • March 18 2014

On 10 March 2014, the European Commission ("Commission") published a report which details the results of an assessment of external reference pricing

CJEU confirms the availability of negative term Supplementary Protection Certificates ("SPCs") in Januvia case

  • Hogan Lovells
  • -
  • European Union
  • -
  • December 8 2011

The Court of Justice of the European Union (CJEU) gave its decision in the Januvia case today, 8 December 2011

European Food Safety Authority publishes first batch of health claim opinions

  • Hogan Lovells
  • -
  • European Union
  • -
  • October 6 2009

On October 1, 2009, the European Food Safety Authority (EFSA) issued a first batch of opinions on health claims that are based on generally established scientific evidence

Blocking or delaying generic versions of drugs: the General Court ruling in the AstraZeneca appeal

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 1 2010

The General Court of the European Union (the "General Court") has today handed down its eagerly awaited judgment in relation to AstraZeneca's appeal against a 2005 decision of the European Commission (the "Commission") finding that AstraZeneca had abused its dominant position by blocking or delaying generic versions of its drug Losec

EU close to deal on foods for particular nutritional uses?

  • Hogan Lovells
  • -
  • European Union
  • -
  • December 4 2012

The European Parliament and the Council appear to have reached agreement, in principle, on the text of a draft Regulation on food intended for infants and young children and food for special medical purposes

EU court delivers judgment in Glaxo “Spanish” case on parallel imports

  • Hogan Lovells
  • -
  • European Union, Spain
  • -
  • November 23 2009

On October 6, 2009, the European Court of Justice handed down a judgment in the Spanish GSK case (See case No. C-50106

EU Parliament committee approves draft Regulations overseeing the revision of EU medical devices legislation

  • Hogan Lovells
  • -
  • European Union
  • -
  • September 26 2013

On Wednesday 25 September 2013, the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI) voted on two draft

The Court of Justice of the European Union declares that the prohibition in the Community Code on provision of inducements to healthcare professionals to prescribe medicinal products does not apply to national health authority policies

  • Hogan Lovells
  • -
  • European Union
  • -
  • April 29 2010

The Court held that the provisions of the European Union (hereafter the "EU") legislation imposing restrictions on the promotion and advertising of medicinal products apply only to pharmaceutical companies and independent third parties

Supplementary protection certificates: can a negative lead to something positive?

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 21 2011

Ever since the introduction of the Pediatric Regulation the question of whether it is permissible to grant a negative or zero term Supplementary Protection Certificate (SPC) has been controversial, with a range of inconsistent decisions across the EU

EPO patent examination guidelines to reflect stem cells ruling

  • Hogan Lovells
  • -
  • European Union
  • -
  • July 20 2012

The European Patent Office (EPO)'s latest revisions to the Guidelines for Examination (in force on 20 June 2012) now reflect the Brüstle ruling of the Court of Justice (CJEU) on the patentability of stem cell inventions using human embryos